Search For "anti viral drug"
Maharashtra Health Minister seeks increase in Remdesivir production, reduc
Updated : 4 years, 11 months ago IST
Jalna (Maharashtra) [India], April 13 (ANI): Maharashtra Health Minister Rajesh Tope has stated that the price of anti-viral drug Remdesivir, which is also used in the treatment of COVID-19, should be reduced to Rs 1,200-Rs 1,300. He also said that the companies manufacturing the anti-viral
Read More
Indore's MGM Medical College new nodal centre for distribution of Remdesiv
Updated : 4 years, 11 months ago IST
Indore (Madhya Pradesh) [India], April 11 (ANI): The Mahatma Gandhi Memorial Medical College (MGM College) of Indore has been made the nodal centre to distribute the anti-viral drug Remdesivir across Madhya Pradesh provided by the state government.
Read More
Drugs regulator refuses application of Dr Reddy's Lab for marketing author
Updated : 5 years, 4 months ago IST
New Delhi [India], November 2 (ANI): The top drug regulator has refused Dr Reddy's Laboratories' application, for full marketing authorization of anti-viral drug Remdesivir, for treatment of COVID-19 patients in India.
Read More
Converge Biotech announces the launch of Vergiflu (Favipiravir 200 mg) in
Updated : 5 years, 7 months ago IST
Hyderabad (Telangana) [India] Aug 4 (ANI/BusinessWire India): Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 8 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted eme
Updated : 5 years, 8 months ago IST
New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on Thursday.
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 9 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 9 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 9 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 9 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More